An observational study in Chest Pain and Acute Coronary Syndrome, sponsored by Yuguo Chen. Status unknown at 7 sites in China. Per ClinicalTrials.gov, last updated 2015-03-10.
Sponsored by Yuguo Chen · Observational
The purpose of this study is to describe the characteristics, evaluation, management and outcomes of acute chest pain, and to provide opportunities for future initiatives to improve the emergency care for patients experiencing acute chest pain in China.
1,461 studies on the registry are indexed under Acute Coronary Syndrome; 267 are open to participants now.
This study's planned enrollment of 18,000 is above the median of 500 across 561 observational studies indexed under Acute Coronary Syndrome.
Browse Acute Coronary Syndrome studies →Yuguo Chen is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
consecutive patients attending the emergency department in 7 Chinese grade Ⅲ hospitals
Exclusion Criteria:
in-hospital mortality
Time frame: During hospital stay,an expected average of 7 days
Time between symptom onset and hospital admission
Time frame: Time interval from symptom onset to arrival at the Emergency Department，an expected median of 9 hours
Major adverse cardiac events (MACE)
Composite of major adverse cardiac events (MACE) including death, myocardial infarction and/or revascularization
Time frame: 1 year
Cost-Effectiveness Analysis
To study the cost-effectiveness ratios of diagnostic and management strategies for patients with acute chest pain
Time frame: 1 year
This study is status unknown, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Yuguo Chen